
Jameela Jamil
Serena Williams’ full-throated endorsement and advertising for weight-loss drugs sparked a string of discussions when Jameela Jamil revealed that the company behind the drugs had very large investments from Serena’s husband, Alexis Ohanian. This actress and activist wrote a long Instagram post demanding transparency and medical cautions, which now has thousands of comments ranging from angry backlash to overwhelming support. The post points out some horrible side effects the pharmaceutical companies see fit to list on their websites and questions the ethics involved—making money off celebrity endorsement.
Advertisement
An argumentative statement could be made to argue that Jamil’s post was certainly not a casual observation but a hard-hitting plea toward informed consent. She emphasized that she was not condemning anyone’s body or personal medical choices. She nevertheless wished to clarify that people deserve to get the right treatment before going into a drug that can wipe away their lives in drastic and sometimes irreversible ways. “Things can go south very fast,” she claims, referring to emerging lawsuits related to these drugs. And while the upside can be remarkable for some, the downside can be utterly devastating for others, hence the preparation in knowledge.
The postscript escalated the drama by saying: “Many people have asked me to highlight the fact that Serena’s husband is an investor in this company.” Suddenly, that gave that conversational thread an even larger angle as Williams’ endorsement then may have not been completely altruistic but a financially motivated one. Jamil went on to state this as “another reason we should take every celebrity endorsement with a pinch of salt.”
So, the comments grew divided and explosive. One commenter passionately thanked Jamil, “Thank you for speaking out around this and continuing to fight the good fight around our once again increasingly fat phobic society.” The comment included a personal shortcoming account of the drugs, “For me the side effects were horrible and not worth it at all as a diabetic.” The camp members of this comment divided into the greater debate, one side claiming Jamil was demonizing “a drug which is medically approved,” while others defended her right to speak transparently.
Another comment sharply pin-pointed the issue for many: “This AND, Serena Williams does not need to be losing weight. She is a role model of strength to young women. Watching her advertise a weight loss program breaks my heart.” This comment had an immediate backlash from the other side claiming none of them really know what is going on with Williams’ private health, nor what her doctors might have actually advised. This then spiraled into this conversation of whether it’s even appropriate for any celebrity to do pharmaceutical endorsements, much less towards weight loss.
The money tie-in ultimately placed a spotlight on the subject, as one user said: “And to know her husband has ties to the company she’s endorsing is also problematic.” Triggering numerous conversations spawned by multiple surprised reactions from many who had no idea Ohanian was invested in the company, with many expressing dismay that this apparently looks like a conflict of interest.
Amid such heated exchanges, some tried to display moderating voices. An endocrinologist from Portugal commented, “I’m an endocrinologist from Portugal. I use these drugs a lot, and they have been revolutionary in obesity treatment.” He or she continued, “What is seriously wrong here is that the US allows drug companies to advertise for their products – which is forbidden in Portugal. Drugs are to be prescribed by doctors, whenever they are appropriate. They should not be marketed like this. So the problem is NOT with the drug, is with the culture.”
The rest of the medical opinion trims right at the core of what is beyond the private squabble between Jamil and Williams: The U.S. is one of only two countries in the world that advertise prescription medications directly to consumers (the other is New Zealand). This commercial climate then allows for an environment where celebrities earn endorsements from drugs that should actually be discussed behind closed doors between patients and their doctors.
“This seems like fear mongering,” accused one of Jamil’s critics, “Very disappointed in this fear mongering post. Stroke is the leading cause of death and disability worldwide. The rates of heart attack and stroke in younger and younger people are skyrocketing because of obesity. GLP1s are literally saving people’s lives.” A series of comments then swiftly followed these remarks, with the majority defending the benefits that outweigh the risks for many patients.
One comment in the conversation quickly turned personal, attacking Jamil’s credibility because of her body type: “And why are you as a thin model type person one to shout about something you know not of.” Jamil responded to this directly in the comment section, asking why her size does not allow her to speak about medical transparency. Many users jumped to Jamil’s defense, pointing out that she has openly discussed her own struggles with eating disorders and is therefore qualified to speak on body image issues.
Now what really pushes this savage to the big time is how it scrapes across headlines of star power, pharmaceutical advertising, body image, medical ethics, and financial transparency. Jamil’s post seemingly hit a sore spot when weight-loss drugs are increasingly becoming a popular and controversial topic.
It revealed a deep divide on the whole advertising of pharmaceuticals. As one person succinctly put it, “I think marketing and ads for drugs should be banned tbh,” a sentiment which earned a lot of support within the comments above. This shows that whether one is on one side of the GLP-1 debate or the other, there is a rising concern over celebrity endorsements in healthcare decisions.
Advertisement
As the dialog now grows, one very real thing that emanates out of Jamil’s post is what she wanted—all-the-more needed discussion on transparency, informed consent, and ethical celebrity endorsements within the pharmaceutical industry. Somebody of whatever view on her is putting very transparent questions on when medications are advertised and who is profiting from such move. That this matter is really being discussed and debated openly by not only medical experts and patients but also serious members of the public is a huge boost for transparency in an area desperately needing it.
You can view the original article HERE.






















